Shot-Induced Cancer, Reproductive Issues, Blood Clots, and So On: How Did the FDA Miss All of This?

Shot-Induced Cancer, Reproductive Issues, Blood Clots, and So On: How Did the FDA Miss All of This?

Dr. Robert Malone: "It goes right back to the original dossier, because the FDA treated this as if it was a normal 'vaccine,' whatever normal vaccine happens to be, and not like a gene therapy product, which is what it was, and they didn't do reproductive toxicology rigorously. They didn't do genome toxicity. They didn't do biodistribution. They didn't do pharmacokinetics. It goes on and on. Why didn't they do their job?"